Carregant...
Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status
Guardat en:
| Publicat a: | Blood Cancer J |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6520396/ https://ncbi.nlm.nih.gov/pubmed/31092813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-019-0207-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|